» Articles » PMID: 11979126

Current Status and Future Prospects of the Global Lymphatic Filariasis Programme

Overview
Date 2002 Apr 30
PMID 11979126
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Lymphatic filariasis is recognized as one of the world's most disabling diseases. Adult lymphatic filarial nematodes live for several years; they infest the lymphatic and blood systems, and are transmitted via mosquito vectors. Acute and chronic disease can develop, manifesting as acute inflammation, hydrocoele, lymphoedema and elephantiasis. The development of a global programme for the elimination of lymphatic filariasis (focusing on disease caused by Wuchereria bancrofti) followed a resolution by the World Health Assembly in 1997 that endemic countries should develop programmes to eliminate lymphatic filariasis as a public health problem. This developed from an earlier recommendation by the International Task Force for Disease Eradication in 1993 that lymphatic filariasis was one of six diseases that could, in theory, be eradicated. Herein we review the current status and future prospects of the Global Lymphatic Filariasis Programme, which was launched in 2000.

Citing Articles

Repurposed Drugs That Activate Autophagy in Filarial Worms Act as Effective Macrofilaricides.

Voronin D, Tricoche N, Peguero R, Kaminska A, Ghedin E, Sakanari J Pharmaceutics. 2024; 16(2).

PMID: 38399310 PMC: 10891619. DOI: 10.3390/pharmaceutics16020256.


Aspartyl Protease Inhibitors as Anti-Filarial Drugs.

Beld L, Jung H, Bulman C, Rosa B, Fischer P, Janetka J Pathogens. 2022; 11(6).

PMID: 35745561 PMC: 9227574. DOI: 10.3390/pathogens11060707.


An Integrated Approach to Identify New Anti-Filarial Leads to Treat River Blindness, a Neglected Tropical Disease.

Tyagi R, Bulman C, Cho-Ngwa F, Fischer C, Marcellino C, Arkin M Pathogens. 2021; 10(1).

PMID: 33466870 PMC: 7830784. DOI: 10.3390/pathogens10010071.


The use of molecular xenomonitoring for surveillance of mosquito-borne diseases.

Cameron M, Ramesh A Philos Trans R Soc Lond B Biol Sci. 2020; 376(1818):20190816.

PMID: 33357052 PMC: 7776931. DOI: 10.1098/rstb.2019.0816.


The endosymbiont Wolbachia rebounds following antibiotic treatment.

Gunderson E, Vogel I, Chappell L, Bulman C, Lim K, Luo M PLoS Pathog. 2020; 16(7):e1008623.

PMID: 32639986 PMC: 7371230. DOI: 10.1371/journal.ppat.1008623.